Stock listing
NASDAQ:IBRX ImmunityBio, Inc. Stock
Home listing (NASDAQ) of ImmunityBio, Inc.
Follow ImmunityBio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IBRX
$8.29 USD -0.45 (-5.1%)
Close on Oct 30, 2026
- Day range
- $8.12 – $8.72 USDOct 30, 2026
- Volume
- 8.91M sharesOct 30, 2026
- Market cap
- $8.79B USDAt the close on Oct 30, 2026 · price × 1.06B shares outstanding
- 52-week range
- $1.95 – $12.43 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $99.33M USDMedian day 9.47M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IBRX · Home | $8.29 USD | -0.45 (-5.1%) | 8,911,096 | $8.48 | $8.72 | $8.122 | $8.74 | Close on Oct 30, 2026 |
| Frankfurt:26CA | €7.41 EUR | -0.29 (-3.8%) | — | €7.64 | €7.64 | €7.27 | €7.70 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IBRX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.29 | -0.45 | -5.1% | $8.48 | $8.72 | $8.122 | 8,911,096 | |
| $8.74 | -0.07 | -0.8% | $8.75 | $8.935 | $8.56 | 7,113,047 | |
| $8.81 | +0.18 | +2.1% | $8.66 | $8.83 | $8.48 | 7,136,872 | |
| $8.63 | +0.82 | +10.5% | $7.84 | $8.685 | $7.765 | 10,486,483 | |
| $7.81 | -0.41 | -5.0% | $8.255 | $8.28 | $7.75 | 10,960,202 | |
| $8.22 | -0.09 | -1.1% | $8.22 | $8.355 | $8.05 | 5,922,752 | |
| $8.31 | -0.33 | -3.8% | $8.51 | $8.84 | $8.02 | 12,731,345 | |
| $8.64 | -0.13 | -1.5% | $8.88 | $8.99 | $8.32 | 11,462,803 | |
| $8.77 | +0.35 | +4.2% | $8.31 | $8.90 | $8.11 | 13,971,629 | |
| $8.42 | -0.76 | -8.3% | $9.19 | $9.697 | $8.31 | 19,509,986 | |
| $9.18 | -0.82 | -8.2% | $10.02 | $10.02 | $9.02 | 21,485,000 | |
| $10.00 | +0.09 | +0.9% | $10.20 | $10.50 | $9.815 | 20,010,100 | |
| $9.91 | +0.11 | +1.1% | $9.69 | $10.46 | $9.35 | 30,228,600 | |
| $9.80 | -0.32 | -3.2% | $10.00 | $10.06 | $9.56 | 11,604,000 | |
| $10.12 | -0.39 | -3.7% | $10.59 | $10.62 | $10.05 | 11,057,100 | |
| $10.51 | +0.60 | +6.1% | $9.95 | $10.80 | $9.87 | 18,657,500 | |
| $9.91 | +0.16 | +1.6% | $9.63 | $10.05 | $9.43 | 10,492,100 | |
| $9.75 | +0.06 | +0.6% | $9.50 | $9.93 | $9.33 | 11,780,000 | |
| $9.69 | -0.69 | -6.6% | $10.33 | $10.36 | $9.61 | 16,887,000 | |
| $10.38 | +0.095 | +0.9% | $10.76 | $10.81 | $10.13 | 16,866,900 | |
| $10.29 | +1.005 | +10.8% | $9.39 | $10.55 | $9.39 | 31,251,600 | |
| $9.28 | -0.16 | -1.7% | $9.28 | $9.40 | $9.07 | 12,313,700 | |
| $9.44 | +0.61 | +6.9% | $8.92 | $10.09 | $8.90 | 27,286,800 | |
| $8.83 | +0.31 | +3.6% | $8.52 | $8.88 | $8.52 | 8,366,600 | |
| $8.52 | +0.08 | +0.9% | $8.39 | $8.979 | $8.26 | 10,413,600 | |
| $8.44 | -0.20 | -2.3% | $8.76 | $8.84 | $8.41 | 5,819,400 | |
| $8.64 | +0.01 | +0.1% | $8.50 | $8.675 | $8.31 | 8,980,000 | |
| $8.63 | -0.66 | -7.1% | $9.26 | $9.29 | $8.60 | 13,954,500 | |
| $9.29 | +0.84 | +9.9% | $8.45 | $9.48 | $8.37 | 21,133,200 | |
| $8.45 | -0.03 | -0.4% | $8.72 | $8.87 | $8.26 | 12,238,200 | |
| $8.48 | +0.02 | +0.2% | $8.46 | $8.53 | $8.20 | 18,428,900 | |
| $8.46 | +0.55 | +7.0% | $8.14 | $8.80 | $8.12 | 19,159,300 | |
| $7.91 | -0.23 | -2.8% | $8.135 | $8.30 | $7.76 | 9,205,000 | |
| $8.14 | -0.23 | -2.7% | $8.32 | $8.34 | $7.85 | 8,949,300 | |
| $8.37 | +0.46 | +5.8% | $7.89 | $8.40 | $7.87 | 9,158,300 | |
| $7.91 | +0.19 | +2.5% | $7.80 | $8.345 | $7.80 | 12,468,800 | |
| $7.72 | -0.34 | -4.2% | $7.87 | $7.89 | $7.64 | 8,797,200 | |
| $8.06 | -0.23 | -2.8% | $8.22 | $8.36 | $7.875 | 9,485,900 | |
| $8.29 | +0.21 | +2.6% | $8.00 | $8.37 | $7.93 | 7,735,300 | |
| $8.08 | -0.11 | -1.3% | $8.08 | $8.24 | $8.01 | 4,324,700 | |
| $8.19 | +0.24 | +3.0% | $8.00 | $8.21 | $7.88 | 5,271,800 | |
| $7.95 | +0.08 | +1.0% | $7.945 | $8.28 | $7.755 | 7,228,300 | |
| $7.87 | -0.08 | -1.0% | $7.82 | $7.99 | $7.73 | 6,460,300 | |
| $7.95 | -0.10 | -1.2% | $7.88 | $8.02 | $7.84 | 6,873,400 | |
| $8.05 | -0.35 | -4.2% | $8.31 | $8.32 | $7.945 | 7,980,000 | |
| $8.40 | +0.15 | +1.8% | $8.24 | $8.76 | $8.18 | 12,311,500 | |
| $8.25 | +0.06 | +0.7% | $8.17 | $8.40 | $8.07 | 9,446,500 | |
| $8.19 | +0.61 | +8.0% | $7.69 | $8.23 | $7.68 | 11,547,390 | |
| $7.58 | -0.21 | -2.7% | $7.68 | $7.72 | $7.46 | 5,671,527 | |
| $7.79 | -0.05 | -0.6% | $7.85 | $7.95 | $7.60 | 7,619,700 | |
| $7.84 | -0.29 | -3.6% | $7.90 | $8.00 | $7.74 | 8,099,200 | |
| $8.13 | +0.41 | +5.3% | $8.08 | $8.27 | $7.94 | 13,063,700 | |
| $7.72 | -0.20 | -2.5% | $7.785 | $7.83 | $7.54 | 5,413,300 | |
| $7.92 | +0.35 | +4.6% | $7.55 | $7.95 | $7.44 | 6,816,500 | |
| $7.57 | -0.08 | -1.0% | $7.59 | $7.59 | $7.43 | 4,912,700 | |
| $7.65 | -0.09 | -1.2% | $7.80 | $7.955 | $7.59 | 6,006,700 | |
| $7.74 | +0.14 | +1.8% | $7.71 | $7.82 | $7.60 | 5,340,400 | |
| $7.60 | +0.11 | +1.5% | $7.54 | $7.66 | $7.48 | 5,033,000 | |
| $7.49 | -0.15 | -2.0% | $7.51 | $7.70 | $7.42 | 6,001,600 | |
| $7.64 | +0.32 | +4.4% | $7.40 | $7.65 | $7.25 | 9,391,500 | |
| $7.32 | +0.07 | +1.0% | $7.24 | $7.49 | $7.185 | 7,786,700 | |
| $7.25 | +0.30 | +4.3% | $6.96 | $7.41 | $6.94 | 11,508,300 | |
| $6.95 | -0.20 | -2.8% | $6.76 | $7.26 | $6.70 | 19,006,800 | |
| $7.15 | -0.02 | -0.3% | $7.18 | $7.415 | $7.10 | 8,755,800 | |
| $7.17 | -0.28 | -3.8% | $7.45 | $7.62 | $7.10 | 9,366,000 | |
| $7.45 | +0.62 | +9.1% | $7.22 | $7.47 | $7.00 | 11,162,000 |
- Ticker
- NASDAQ:IBRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 33 slides
Latest news
ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer
Oct 21, 2026
Closed $8.64 (-1.5%) on Oct 21, 2026
ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors
Oct 16, 2026
Closed $9.18 (-8.2%) on Oct 16, 2026
FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
Oct 14, 2026
Closed $10.00 (+0.9%) on Oct 15, 2026
ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium
Oct 8, 2026
Closed $9.91 (+1.6%) on Oct 8, 2026
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman
Aug 10, 2026
Closed $7.49 (-2.0%) on Aug 10, 2026
ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million
Aug 4, 2026
Closed $6.95 (-2.8%) on Aug 4, 2026
ImmunityBio Receives United Arab Emirates Marketing Authorization for ANKTIVA across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer
Jul 30, 2026
Closed $7.45 (+9.1%) on Jul 30, 2026
ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026
Jun 1, 2026
Closed $7.24 (-3.7%) on Jun 1, 2026
ImmunityBio Presents Health Economic Analysis at ISPOR 2026 Showing ANKTIVA® Plus BCG Delivers Lower Cost per Sustained Complete Response Versus TAR-200 in BCG-Unresponsive NMIBC CIS
May 22, 2026
Closed $7.22 (-6.7%) on May 22, 2026
ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
May 22, 2026
Closed $7.22 (-6.7%) on May 22, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 33 slides · August 2026
Milken Institute Presentation 2026
Conference · 67 slides · Feb 24, 2026
Investor Presentation (November 2022)
Investor deck · 30 slides · Nov 15, 2022
Jefferies Healthcare Conference 2022
Conference · 32 slides · Jun 10, 2022
ImmunityBio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 49 in the last 12 months · 203 in all · newest Oct 21, 2026 · oldest 2019
- Decks
- 10 decks · latest August 2026
Where ImmunityBio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IBRX · Home listing · This page | NASDAQ | United States | USD |
| gettex:26CA | gettex | Germany | EUR |
| LS Exchange:A2QQ2E | LS Exchange | Germany | EUR |
| Tradegate:26CA | Tradegate | Germany | EUR |
| BOATS:IBRX | BOATS | United States | USD |
| Frankfurt:26CA | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QQ2E | Lang & Schwarz | Germany | EUR |
| Dusseldorf:26CA | Dusseldorf | Germany | EUR |
| Stuttgart:26CA | Stuttgart | Germany | EUR |
| Munich:26CA | Munich | Germany | EUR |
| Hamburg:26CA | Hamburg | Germany | EUR |
| Hanover:26CA | Hanover | Germany | EUR |
| Xetra:26CA | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about ImmunityBio, Inc.